279
Participants
Start Date
May 14, 2013
Primary Completion Date
May 1, 2018
Study Completion Date
September 26, 2018
PEGPH20
PEGPH20 will be administered as per the dose and schedule specified in the respective arms.
Nab-paclitaxel
Nab-paclitaxel will be administered as per the dose and schedule specified in the respective arms.
Gemcitabine
Gemcitabine will be administered as per the dose and schedule specified in the respective arms.
Dexamethasone
Dexamethasone will be administered as per the dose and schedule specified in the respective arms.
Enoxaparin
Enoxaparin will be administered as per the dose and schedule specified in the respective arms.
Mount Sinai Medical Center, New York
Columbia University Medical Center, New York
North Shore Long Island Jewish Health System, Lake Success
Roswell Park Cancer Institute, Buffalo
University of Rochester, Rochester
UPMC Cancer Center, Pittsburgh
Georgetown University Medical Center, Washington D.C.
Johns Hopkins University Hospital, Baltimore
Greenville Health System, Greenville
Piedmont Hospital, Atlanta
University of Miami, Sylvester comprehensive Cancer Center, Miami
H. Lee Moffit Cancer Center, Tampa
Alabama Oncology, Birmingham
University of South Alabama Mitchell Cancer Institute, Mobile
Norton Cancer Institute - Norton HealthCare Pavilion, Louisville
Gabrail Cancer Center, Canton
University of Michigan, Ann Arbor
Froedtert Hospital, Medical College of Wisconsin, Milwaukee
University of Wisconsin Hospitals and Clinics, Madison
Virginia Piper Cancer Institute, Minneapolis
Unniversity of Minnesota, Minneapolis
Loyola University Medical Center, Maywood
Washington University School of Medicine, St Louis
Research Medical Center, Kansas City
Highlands Oncology Group, Fayetteville
University of Oklahoma Health Science Center, Oklahoma City
Texas Oncology - Baylor, Dallas
Texas Oncology, Tyler
Cancer Care Centers of South Texas, New Braunfels
University of Colorado Cancer Center, Aurora
Rocky Mountain Cancer Center, Denver
Banner MD Anderson Cancer Center, Gilbert
Mayo Clinic - Scottsdale, Scottsdale
Arizona Oncology Associates, PC, Tucson
Comprehensive Cancer Centers of Nevada, Las Vegas
Cedars-Sinai Medical Center, Los Angeles
The Oncology Institute of Hope and Innovation, Whittier
Providence St Joseph Medical Center, Burbank
Scripps Cancer Center, La Jolla
UCSD - Moore's Cancer Center, La Jolla
University of California Medical Center, Orange
Pacific Hematology Oncology Associates, San Francisco
Saint Helena Hospital, St. Helena
Seattle Cancer Care Alliance, Seattle
NorthWest Medical Specialties, PLLC, Tacoma
Columbia Basin Hematology and Oncology, Kennewick
Stamford Hospital, Stamford
Beth Israel Deaconess Medical Center, Boston
Lahey Clinic, Burlington
University of Mass Medical School, Worcester
St. Joseph's Regional Medical Center, Paterson
Lead Sponsor
Halozyme Therapeutics
INDUSTRY